DORC is one of the world’s leading suppliers of equipment, instruments and liquids for ophthalmic surgery. Learn more. We aim to take a leading role in driving sustainability in ophthalmic surgical healthcare. LEARN more. VisionBlue® anterior stain: trusted for over 10 million cataract surgeries since launch. Learn more.

DORC is one of the world’s leading suppliers of equipment, instruments and liquids for ophthalmic surgery. The company improves eye surgery globally and maximizes surgeon control by providing innovative quality approaches for eye disorders.

Dec 15, 2023 · Carl Zeiss Meditec AG (ISIN: DE0005313704) announces today that it has entered into a definitive agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), from the investment firm Eurazeo SE, Paris, France (ISIN: FR0000121121).

Apr 4, 2024 · Carl Zeiss Meditec AG announced today that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France.

Apr 4, 2024 · Carl Zeiss Meditec AG announced today that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France.

In late 2023, Carl Zeiss Meditec AG, one of the world's leading medical technology companies, announced its intent to acquire D.O.R.C.. The acquisition was completed on April 4, 2024, bringing together two ophthalmic powerhouses.

a) The ZEISS logo is always surrounded by a white space. b) The logo must be at least large enough for the ZEISS lettering to be clearly visible. The minimum heights for the ZEISS logo are: print 8.4 mm, screen 45 px. c) The brand color may only be used for the ZEISS logo and, under no circumstances, for any other design element. d) The ZEISS ...

The ZEISS Medical Technology segment offers complete solutions to diagnose and treat ophthalmic diseases. Like DORC, ZEISS drives progress, efficiency and access to healthcare technology, enabling physicians to improve the quality of life of their patients.

Apr 4, 2024 · ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion …

Apr 3, 2024 · Eurazeo has completed the disposal of DORC (“Dutch Ophthalmic Research Center”) to Carl Zeiss Meditec AG, one of the world’s leading medical technology companies.